A detailed history of Redwood Park Advisors LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Redwood Park Advisors LLC holds 311 shares of BMY stock, worth $16,927. This represents 0.01% of its overall portfolio holdings.

Number of Shares
311
Holding current value
$16,927
% of portfolio
0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$51.92 - $59.94 $16,147 - $18,641
311 New
311 $17.6 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $116B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Redwood Park Advisors LLC Portfolio

Follow Redwood Park Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redwood Park Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redwood Park Advisors LLC with notifications on news.